1 Department of Medicine and Duke University School of Medicine, Durham, North Carolina.
2 Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina.
J Palliat Med. 2019 Mar;22(3):319-325. doi: 10.1089/jpm.2018.0641. Epub 2019 Jan 14.
The use of medical cannabis is increasing significantly throughout the United States in spite of limited and sometimes contradictory data about its effectiveness. Palliative care providers are being asked to consider cannabis as part of symptom-directed treatment regimens although many providers have limited experience recommending medical cannabis and were trained before it was commercially available. This article seeks to dispel myths about medical cannabis and provides a balanced view of the benefits and burdens of this therapeutic option, providing evidence where it exists and offering practicing clinicians guidance on conditions in which medical cannabis is likely to be helpful or burdensome.
尽管关于医用大麻的有效性的数据有限且有时相互矛盾,但在美国,其使用量正在大幅增加。姑息治疗提供者被要求将大麻视为症状导向治疗方案的一部分,尽管许多提供者在大麻上市之前就有限的推荐医用大麻的经验,并且接受过培训。本文旨在消除有关医用大麻的误解,并提供对这种治疗选择的益处和负担的平衡看法,在存在证据的情况下提供证据,并为临床医生提供有关医用大麻可能有帮助或负担的条件的指导。